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o the Editor,
Polyomaviruses have been associated with cen-
ral nervous system (CNS) disease in humans,
ncluding brain tumors [1] and infections. Among
he many members of the Polyomaviridae family
hat have been found to infect humans (BK virus,
C virus, simian virus 40, KI virus, WU virus and
erkel cell virus), JC virus is a very well known
eurotropic agent, being the etiologic factor of pro-
ressive multifocal leukoencephalopathy (PML), a
emyelinating disease of the CNS. On the other
and, BK virus (BKV) is associated with genitouri-
ary tract disease (tubulo-interstitial nephritis and
emorrhagic cystitis). In the last two decades how-
ver, BK virus has been increasingly reported and
ecognized as an opportunistic infectious agent of
he CNS in immunosuppressed persons with T-cell
eﬁciencies, mainly AIDS and transplant patients
2—4] (Fig. 1). Primary asymptomatic BKV infection
sually occurs during childhood via the respiratory
ract and after then latent infection is established
n renal epithelial cells and possibly other tis-
ues, including brain [5]. The concept of BKV brain
atency is controversial with studies showing con-
icting results [2,3]. However, the discovery of
KV variants with reorganized noncoding control
egion that confers better adaptation to the host
ell machinery of the CNS favours the emerging
oncept that this virus has also neurotropism [6].
t
o
c
876-0341/$ — see front matter © 2011 King Saud Bin Abdulaziz University for Health
oi:10.1016/j.jiph.2011.02.002esides, BKV curiously appears to be able to induce
clinical and radiological picture of PML in patients
ithout any evidence of JC virus infection [7,8].
NS BKV infection manifests as meningoencephali-
is with or without retinitis and in many cases
s associated with disseminated viral disease and
ulti-organ failure. In neuroimaging, BKV infection
hows a predilection for the periventricular and pial
urfaces of the brain parenchyma, with the cor-
ex being spared [4]. Diagnosis of BKV CNS disease
as usually been established by polymerase chain
eaction of the cerebrospinal ﬂuid and brain biopsy
pecimen, which can be reinforced by immunohis-
ochemical staining for the two BKV proteins, the
P1 and the agnoprotein [2—4].
Despite being increasingly recognized as a poten-
ial opportunistic neurotropic pathogen, various
ssues still need to be properly addressed.
Firstly, it is clear that BKV is assuming now
n important role as an emerging viral infection
f the CNS and adds to the continuing growing
ist of other neurotropic viruses, however although
ome insights have been revealed, the exact
echanism of BKV neurovirulence remains to be
lucidated and much more investigation is needed.
econdly, BKV associated neurological disease is
enerally underreported since it occurs mainly in
he immunocompromised host where a myriad of
ther more common infectious agents are often
onsidered more probable during the differential
Sciences. Published by Elsevier Ltd. All rights reserved.
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Figure 1 Distribution (%) of the cases of BKV CNS infec-
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∗tion reported in the literature [2—4]. Legends: HM,
hematological malignancies; CT, chemotherapy; HSCT,
hematopoietic stem cell transplant.
diagnosis. This is very true in AIDS patients and
in renal/hematopoietic stem cell transplant recip-
ients where the immunosupressed state renders
the patient virtually susceptible to any kind of
infection, and coexistence of multiple infectious
pathogens in the same patient sometimes difﬁcult
the recognition of BKV as the central cause of CNS
disease. The delay in the diagnosis has proven to be
fatal in most cases so the clinicians must be aware
of the possibility of BKV as the etiologic factor of
CNS disease [4].
Thirdly, although we have recently witnessed
therapeutical advances with new drugs (cidofovir,
leﬂunomide and ciproﬂoxacin) to ﬁght BKV in the
context of nephritis and hemorrhagic cystitis, their
efﬁcacy still remain to be proven and there is not
any data regarding antiviral treatment in the con-
text of BKV CNS infection. This lack of effective
antivirals poses clinical challenges in treating BKV
infected patients in the context of renal or bone
marrow transplantation setting where the best way
to control BKV infection is to reduce the immuno-
suppression. However this attitude brings the great
risk of compromising the transplant procedure itself
due to graft rejection, which remains a central
issue and is associated with dismal results. In AIDS
patients, owing to the better control of the infec-
tion with combined anti-retroviral therapy, the ﬁnal
outcome appears to be more favourable, although
more data is necessary to support this [9].In summary, particular focus should be given
nowadays in the transplant setting where intensive
and prolonged immunosuppression due to pre-
transplant conditioning regiments and use of potent
Available online at www.sLetter to the Editor
mmunosuppressors like the calcineurin inhibitors
ay create a favourable ground for BKV reacti-
ation and pave the way for disseminated viral
isease including CNS infection. So, a great index
f suspicion is necessary to make the correct
iagnosis of this potentially fatal disease in the
mmunocompromised patient, particularly those
ith a concomitant urologic disease and neurologi-
al deterioration.
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